Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 3 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation.
J Diabetes Investig. 2021 May;12(5):697-709. doi: 10.1111/jdi.13478. Epub 2020 Dec 31.
J Diabetes Investig. 2021.
PMID: 33314682
Free PMC article.
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.
Srivastava SP, Goodwin JE, Kanasaki K, Koya D.
Srivastava SP, et al.
Br J Pharmacol. 2020 Aug;177(16):3691-3711. doi: 10.1111/bph.15087. Epub 2020 Jun 22.
Br J Pharmacol. 2020.
PMID: 32352559
Free PMC article.
Item in Clipboard
CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.
Mizunuma Y, Kanasaki K, Nitta K, Nakamura Y, Ishigaki Y, Takagaki Y, Kitada M, Li S, Liu H, Li J, Usui I, Aso Y, Koya D.
Mizunuma Y, et al.
J Diabetes Investig. 2020 Nov;11(6):1470-1481. doi: 10.1111/jdi.13311. Epub 2020 Jul 3.
J Diabetes Investig. 2020.
PMID: 32472621
Free PMC article.
Item in Clipboard
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet.
Takagi S, Li J, Takagaki Y, Kitada M, Nitta K, Takasu T, Kanasaki K, Koya D.
Takagi S, et al.
J Diabetes Investig. 2018 Sep;9(5):1025-1032. doi: 10.1111/jdi.12802. Epub 2018 Mar 12.
J Diabetes Investig. 2018.
PMID: 29352520
Free PMC article.
Item in Clipboard
Cite
Cite